MH-Flux+ ™

Is a novel patented technology to increase saliva flow.

Back to Technologies

Safely and effectively increases the saliva production.

  • MH-Flux+ has been found to be effective in stimulating saliva of xerostomicpatients in two independent clinical studies;
  • Improved salivation resulted in a significant satisfaction of the patients and in a restoration of saliva pH;
  • A correct salivation together with the maintenance of the physiological pH value are required to avoid caries, dental erosion, periodontal disease, Halitosis.

01 – Supportive care in cancer, 2017, 25(2), S157 – DOI:10.1007/s00520-017-3704-x. Effects on salivation of the muco-adhesive dietary supplement aqualief in xerostomic patients: a randomized multicenter double-blind placebo controlled pilot study
Macchi F, Levrini L, Rumio C, Aldini G

02 – Clin Ter 2020; 171 (4):e295-301. DOI: 10.7417/CT.2020.2231. The Efficacy of a Dietary Supplement with Carnosine and Hibiscus Sabdariffa L. (AqualiefTM) in Patients with Xerostomia: a Randomized, Placebo-Controlled, Double-Blind Trial.
L. Levrini et al.

03 – Cancers 2021, 13, 3456. DOI:10.3390/cancers13143456. Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of Aqualief Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia.
Iacovelli et al.